Novavax Inc (NVAX) returns
Novavax returns over 10 years
$1,000 invested in Novavax ten years ago was worth $350.00 at the close on October 30, 2026, with dividends reinvested: an average return of -10.0% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -6.8% | — | $932.47 | -0.9% |
| 3 months | +35.5% | — | $1,355 | +2.1% |
| Year to date | +50.0% | — | $1,500 | +11.7% |
| 1 year | +19.6% | — | $1,196 | +12.4% |
| 3 years | +54.6% | +15.6% | $1,546 | +88.5% |
| 5 years | -93.2% | -41.6% | $67.73 | +76.0% |
| 10 years | -65.0% | -10.0% | $350.00 | +316.6% |
Novavax return by calendar year
| Year | NVAX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +50.0% | +11.7% | +38.3% |
| 2025 | -16.4% | +17.7% | -34.1% |
| 2024 | +67.5% | +24.9% | +42.6% |
| 2023 | -53.3% | +26.2% | -79.5% |
| 2022 | -92.8% | -18.2% | -74.6% |
| 2021 | +28.3% | +28.7% | -0.4% |
| 2020 | +2,702% | +18.4% | +2,683% |
| 2019 | -89.2% | +31.2% | -120.4% |
| 2018 | +48.4% | -4.6% | +52.9% |
| 2017 | -1.6% | +21.7% | -23.3% |
| 2016 | -85.0% | +12.0% | -97.0% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: NVAX financials
No forecast, no recommendation. This page describes Novavax Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.